| scholarly article | Q13442814 |
| P50 | author | Chen-Hsin Chen | Q90029101 |
| P2093 | author name string | W. E. Evans | |
| C. F. Stewart | |||
| J. V. Simone | |||
| W. R. Crom | |||
| M. Abromowitch | |||
| W. P. Bowman | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Intensive chemotherapy of small cell bronchogenic carcinoma | Q34017688 | ||
| Membrane transport of methotrexate in human lymphoblastoid cells | Q40668045 | ||
| Drug dosage and remission duration in childhood lymphocytic leukemia | Q44949634 | ||
| High-performance liquid chromatographic assay of methotrexate, 7-hydroxymethortrexate, 4-deoxy-4-amino-N10-methylpteroic acid and sulfamethoxazole in serum, urine and cerebrospinal fluid | Q70454210 | ||
| Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children | Q70896810 | ||
| Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion | Q70982842 | ||
| Five-year follow-up of "total therapy" of childhood lymphocytic leukemia | Q71050827 | ||
| Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemia | Q72057965 | ||
| Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia | Q72425520 | ||
| CLINICAL STUDIES OF DICHLOROMETHOTREXATE (NSC 29630) | Q78342759 | ||
| P433 | issue | 8373 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | methotrexate | Q422232 |
| P304 | page(s) | 359-362 | |
| P577 | publication date | 1984-02-01 | |
| 1984-02-18 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia | |
| P478 | volume | 1 |
| Q68852478 | 6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia |
| Q68617419 | 7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia |
| Q37187510 | Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia |
| Q58392299 | Adolescents in Clinical Trials |
| Q67902980 | Can primary osteosarcoma act as a third space after high-dose methotrexate? |
| Q38396089 | Cancer chemotherapy in infants and children |
| Q68631789 | Chromatographic analysis of anticancer drugs |
| Q39647429 | Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity |
| Q38649105 | Clinical pharmacokinetics-pharmacodynamics of anticancer drugs |
| Q38700644 | Clinical pharmacology of cancer chemotherapy in children. |
| Q30011307 | Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma |
| Q36377551 | Do anticancer agents reach the tumor target in the human brain? |
| Q41532868 | Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies? |
| Q36936674 | Drug metabolism in carcinogenesis and cancer chemotherapy |
| Q34780653 | Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancer |
| Q33774499 | Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia |
| Q36595293 | Genome-wide study of methotrexate clearance replicates SLCO1B1. |
| Q37474395 | Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects |
| Q67902968 | How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia |
| Q36478646 | Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy |
| Q69392789 | Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes |
| Q55314183 | Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate. |
| Q72281579 | Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics |
| Q40534577 | Methotrexate pharmacokinetics and survival in osteosarcoma |
| Q36576663 | Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma |
| Q73514183 | On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia |
| Q67927809 | PharmCalc: program for the calculation of clinical pharmacokinetic parameters of methotrexate |
| Q36890315 | Pharmacokinetic optimisation of anticancer therapy |
| Q74639732 | Pharmacokinetics of anticancer agents in patients with impaired liver function |
| Q39768346 | Pharmacokinetics of anticancer drugs in children |
| Q69688068 | Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate |
| Q68202669 | Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia |
| Q52876874 | Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia. |
| Q51928567 | Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia. |
| Q39733536 | Potential applications of therapeutic drug monitoring in treatment of neoplastic disease by antineoplastic agents |
| Q68759827 | Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia |
| Q52599791 | Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia. |
| Q35634476 | Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition |
| Q58105414 | Renal Function and Plasma Methotrexate Concentrations Predict Toxicities in Adults Receiving High-Dose Methotrexate |
| Q35992880 | The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia |
| Q39673269 | Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy |
| Q40911128 | Therapeutic drug monitoring opportunities in cancer therapy |
| Q41705952 | Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs |
| Q73596981 | Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables |
Search more.